Power Law company profile

Astex

Biotech & Life Sciences · Pleasanton, United States · Founded 1999 Thoroughbred

University of Cambridge spinout, now part of Taiho Oncology, Inc., specializing in fragment-based drug discovery for oncology and CNS disorders

Revenue

$100–500M

Latest reported FY

Unlock exact value

Headcount

<100

Current team size

Unlock exact value

Featured in $10B+ revenueThoroughbred · Power Law outcome

Investors

1 investor on Astex's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series B+ 1 investor entered at this stage

University of Cambridge

Global footprint

Where Astex has talent and traffic

Workforce by country

4 countries with
team presence

🇺🇸 United States63.2%

🇬🇧 United Kingdom30.5%

🇯🇵 Japan3.2%

🇨🇦 Canada3.2%

4 countries shown

Web traffic by country

6.4K monthly visits
across markets

🇺🇸 United States54.7%

🇬🇧 United Kingdom43.8%

🇮🇳 India18.8%

Top 3 markets shown

Market sentiment

What the market is saying about Astex

An AI-synthesized read of the highest-engagement posts about Astex on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Astex on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles